10th Patient Centricity & Collaboration World Congress 2027 Europe

Patient Partnership as the Engine of Innovation, Equity, and Trust

00Days
00Hours
00Minutes
00Seconds

Co-located with the 3rd DCT, HYBRID & CENTRALISED CLINICAL TRIALS World Congress 2027 Europe

Patient meets Innovation & Collaboration

Patient empowerment and understanding to inspire and create a meaningful impact.

Introduction
Insight
Who Should Attend

We are pleased to welcome you to the 10th Patient Centricity and Collaboration World Congress 2027 Europe, hosted by Facilitate Live. Over three days, we aim to foster meaningful collaboration across the healthcare ecosystem, enabling delegates to gain practical strategies and best practices for addressing emerging challenges, embracing innovation, leveraging new technologies, and advancing patient centric goals.

This year’s congress is anchored by the strategic theme, “Patient Partnership as the Engine of Innovation, Equity, and Trust.” It reflects the growing recognition across the healthcare ecosystem that patient involvement is a critical driver of scientific excellence, operational performance, and sustainable innovation.

The Congress convenes leaders from biopharmaceutical organisations, regulatory bodies, clinical research, digital health, and patient advocacy to examine how patient partnership can be embedded more systematically across the development and delivery lifecycle. As healthcare becomes increasingly digital, decentralised, and data‐driven, organisations must adopt models that integrate patient insights into decision‐making, strengthen transparency, and ensure equitable access to research and care.

Achieving patient centricity requires a shift from traditional, organisation‐led approaches toward structured, patient‐centered frameworks. This includes incorporating patient perspectives into early‐stage development, protocol design, endpoint selection, and communication strategies. It also involves adopting personalised care models that tailor treatments, information, and support to individual needs. Clear, accessible communication remains essential to building trust and enabling informed decision‐making across diverse European populations.

Technology plays a pivotal role in advancing this agenda. Decentralised and hybrid trials, digital monitoring, artificial intelligence, and real‐world evidence offer opportunities to reduce burden, improve data quality, and expand participation. However, these innovations also introduce new complexities related to governance, equity, and patient readiness. Organisations must ensure that digital transformation enhances, not hinders the patient experience, and that solutions are designed with inclusivity, transparency, and regulatory alignment. Globally, the industry has made significant progress in operationalising patient centered approaches. Patient centricity has evolved from a conceptual aspiration into a measurable strategic priority supported by frameworks, metrics, and cross‐functional governance. Yet, as healthcare models continue to evolve and patients become more informed and digitally engaged, achieving true patient centricity remains an ongoing commitment requiring continuous improvement and collaboration.

We look forward to your participation in this year’s Congress and to the insights, partnerships, and strategic discussions that will help shape the future of patient‐driven innovation across Europe.

We look forward to meeting you at the Congress!

Sincerely yours,

Jocelyn Raguindin
Conference Director
Paradigm Global Events / Facilitate Live

GAIN LATEST INSIGHTS ON:

How patient partnership is becoming a strategic engine for innovation, equity, and trust across European healthcare systems
New models of co‐creation that embed patient voice into discovery, development, clinical design, and post‐market decision‐making
Ethical, inclusive approaches to AI‐enabled clinical development that strengthen transparency, fairness, and patient confidence
The evolution of decentralised and hybrid trials designed around patient convenience, digital readiness, and real world feasibility
Human‐centred digital experience design that reduces burden, improves accessibility, and supports diverse patient populations
Modern COAs, digital biomarkers, and experience‐driven endpoints that capture what truly matters to patients
Behavioural science frameworks that enhance adherence, self‐management, and long‐term engagement across chronic conditions
Health literacy strategies that transform complex information into clear, actionable, and culturally relevant communication
Community‐driven engagement models that expand representation, build trust, and reach underserved and research‐naïve populations Real world evidence approaches that illuminate patient experience, tolerability, and long term outcomes beyond traditional trials
Advanced analytics and predictive modelling that improve feasibility, site selection, operational forecasting, and trial performance
Governance structures that ensure responsible, compliant, and patient‐aligned use of digital tools and AI in clinical research
Personalised care strategies that tailor treatments, communication, and support to individual patient needs and preferences
Cross‐functional operating models that integrate patient insights into enterprise‐wide strategy, culture, and decision‐making
The future of patient centric leadership and the capabilities organisations need to thrive in an ethical, digital, inclusive healthcare landscape.

WHO SHOULD ATTEND?

This Congress is beneficial to patients, pharmaceutical, biotech companies, researchers, physicians, patient advocacy groups, regulatory agencies, technology, and healthcare companies.

Network with Presidents, Heads/Chiefs, VPs, Directors, and Managers in the area of:

Patient Engagement & Patient Centricity

President / Head of
Patient Engagement
Chief Patient Officer
VP Patient Centricity
Director, Patient Advocacy & Partnerships
Head of Patient Experience
Global Lead, Patient Insights
Director, Patient Diversity & Inclusion

Clinical Development & Clinical Operations

Head of Clinical Development
VP Clinical Operations
Director, Clinical Innovation
Head of Decentralised & Hybrid Trials
Director, Site Engagement & Trial Enablement
VP Early Development & Trial Strategy

Digital Health, AI & Technology

Chief Digital Officer
VP Digital Health & Innovation
Head of AI in Clinical Development
Director, Digital Trial Solutions
Head of Digital Patient Experience
Director, eConsent / eCOA / Digital Platforms

Real‐World Evidence & Data Science

VP Real‐World Evidence
Head of Real‐World Data & Analytics
Director, Patient‐Reported Outcomes
Head of Epidemiology & Observational Research
Director, Data Strategy & Insights

Medical Affairs & Scientific Strategy

VP Medical Affairs
Head of Medical Excellence
Director, Medical Communications & Education
Head of Evidence Generation
Director, Scientific Strategy & Innovation

Market Access, Value & Health Economics

VP Market Access
Head of HEOR
Director, Value & Access Strategy
Head of Pricing & Reimbursement
Director, Patient Value & Outcomes

Experience Design, Behavioural Science & Communications

Head of Patient Experience Design
Director, Behavioural Science
VP Communications & Patient Information
Director, Health Literacy & Plain Language
Head of Experience Research & Insights

Quality, Ethics & Governance

Chief Ethics & Compliance Officer
Head of Patient Safety
Director, Clinical Quality & Governance
Head of Regulatory Policy & Engagement

Key Industry Expert Speakers

Comfirmed speakers Apply to speak

Schedule

Content Rich Program Agenda! Featuring Keynote Presentations, Stream Sessions, Panel, and Round Table Discussions.

Day 1 25/02/2027
Day 2 26/02/2027

08:00 am - WELCOME COFFEE & REGISTRATION

8:30 am - CHAIRPERSON’S OPENING REMARKS

Hayley Chapman, Senior Program Director, The Synergist

PATIENT CENTRICITY, TRUST, & DIGITAL EMPOWERMENT

8:40 am - OPENING KEYNOTE PANEL: The New Patient‑Centricity Mandate: Trust, Transparency & Co‑Creation

How rising expectations from patients and regulators are reshaping engagement models across the entire development lifecycle
The role of digital tools in strengthening transparency, improving communication, and reducing uncertainty
Practical approaches for embedding patient voice into governance, decision‑making, and organisational culture
What “patient‑first” leadership will require from biopharma organisations between now and 2030

Moderator:
Selena Freisens, MD, Head of Global Medical Affairs, Merz Therapeutics

Panellist:
Gunnar Philip, Head of Medical Affairs Europe Major Markets and Canada, CSL

9:20 am - PLENARY KEYNOTE: AI & Patient Experience: Designing Ethical, Inclusive Digital Journeys

Approaches to ensuring fairness, explainability, and transparency in patient‑facing AI systems
Strategies to improve accessibility and digital literacy for diverse patient populations
Human‑centred design principles that reduce burden and create intuitive digital experiences
Governance guardrails that support safe, responsible, and compliant AI deployment

9:45 am - PLENARY KEYNOTE: Embedding the patient voice into the fabric of drug development

The new era of patient focused drug development
Measuring the impact and value of patient engagement in R&D
Accelerating systematic engagement in R&D
Measuring uptake and impact

Michaela Dinboeck, Head Patient Engagement, Novartis

10:10 am - PLENARY KEYNOTE: Patient Insights to Action: Operationalising Engagement Across the Enterprise*

Turning qualitative patient insights into strategic decisions that influence development and delivery
Building cross‑functional alignment between R&D, medical affairs, commercial, and patient engagement teams
Tools and frameworks for continuous feedback loops that capture evolving patient needs
Metrics and maturity models that demonstrate organisational progress in patient centricity

Selena Freisens, MD, Head of Global Medical Affairs, Merz Therapeutics

10:35 am - MORNING NETWORKING BREAK

11:15 am - SPONSORED SPOTLIGHT: Tech‑Enabled Patient Support Platforms

Personalised engagement journeys that adapt to patient needs and preferences
Digital triage and symptom support tools that improve safety and responsiveness
Scalable automation that enhances efficiency without compromising human connection
Data‑driven optimisation that improves programme performance and patient outcomes

11:45 am - SPONSORED SPOTLIGHT: Next‑Gen Recruitment & Retention Solutions

AI‑supported feasibility modelling that identifies optimal sites and patient populations
Hyper‑targeted outreach strategies that improve diversity and representation
Predictive analytics that anticipate retention risks and guide proactive interventions
Real‑time dashboards that support operational decision‑making and transparency

12:15 pm - SPOTLIGHT PRESENTATION: Digital Tools for Hybrid & Decentralised Trials

Remote monitoring innovations that reduce burden and improve data quality
Communication platforms that strengthen site–patient relationships and responsiveness
Logistics solutions that streamline home‑health and decentralised trial operations
Compliance safeguards that ensure data integrity and regulatory readiness

12:45 pm - SPOTLIGHT PRESENTATION: Patient Storytelling as a Cultural Transformation Tool

Crafting authentic narratives that shift organisational mindsets and behaviours
Co‑creating stories with patient partners to ensure accuracy and lived‑experience representation
Embedding storytelling into training, leadership development, and internal culture
Demonstrating how narrative power influences trial design and care pathways

1:15pm - NETWORKING LUNCH

Afternoon - Topic Focussed Stream Sessions

Patient Engagement, Behavioural Science & Experience Design

2:15 pm - SESSION CHAIR OPENING REMARKS

2:20 pm - Behavioural Science for Better Adherence & Self‑Management

Understanding patient motivations and barriers that influence long‑term adherence
Designing behavioural nudges that support sustained engagement and healthier habits
Personalised adherence pathways tailored to individual needs and disease contexts
Measuring behavioural outcomes to demonstrate meaningful patient impact

2:45 pm - SPOTLIGHT PRESENTATION: Patient- Centric Content & Engagement Platforms

Automated personalisation that tailors content to patient preferences and behaviours
Multilingual and accessible formats that broaden reach and inclusivity
Engagement analytics that reveal patterns and guide continuous improvement
Compliance‑ready workflows that ensure safe, consistent communication

3:15 pm - Health Literacy for the Digital Era

Simplifying complex medical information without losing scientific accuracy
Designing digital content that is accessible, intuitive, and culturally relevant
Supporting low‑literacy and multilingual populations through tailored communication
Testing comprehension and usability to ensure messages truly resonate

3:40 pm - AFTERNOON NETWORKING BREAK

4:20 pm - Building Trust Through Transparent Communication

Communicating risk, uncertainty, and benefit in ways that empower patient decision‑making
Improving clarity and consistency in clinical trial messaging across channels
Using patient stories to build emotional connection and strengthen trust
Avoiding misinformation pitfalls through proactive, evidence‑based communication

4:45 pm - Community Partnerships for Representative Engagement

Collaborating with grassroots organisations to reach underrepresented communities
Building trust with “research‑naïve” populations through sustained local engagement
Strengthening diversity in insights and trial participation through community‑led approaches
Creating long‑term partnerships that extend beyond individual studies

5:10 pm - Experience Mapping Across the Patient Journey

Collaborating with grassroots organisations to reach underrepresented communities
Building trust with “research‑naïve” populations through sustained local engagement
Strengthening diversity in insights and trial
participation through community‑led approaches
Creating long‑term partnerships that extend beyond individual studies

Clinical Research & Development, RWE & Digital Innovation

2:15 pm - SESSION CHAIR OPENING REMARKS

2:20 pm - Embedding Patient Insights Across the Lifecycle

Capturing early‑stage discovery insights that inform target selection and design
Integrating patient perspectives throughout clinical development and protocol design
Leveraging post‑launch feedback to refine support programmes and communication
Building organisational capability for continuous patient involvement

2:45 pm - SPOTLIGHT PRESENTATION: Advanced Analytics for Clinical Operations

Predictive enrolment modelling that improves planning and resource allocation
Automated site performance insights that highlight risks and opportunities
Risk‑based monitoring tools that enhance quality and operational efficiency
Operational intelligence dashboards that support real‑time decision‑making

3:15 pm - Digital Biomarkers & Remote Monitoring

Emerging sensor‑based endpoints that capture continuous, real‑world patient data
Remote monitoring approaches that enhance safety and early signal detection
Integrating digital biomarkers into clinical workflows and decision‑making
Navigating regulatory considerations for novel digital endpoints

3:40 pm - AFTERNOON NETWORKING BREAK

4:20 pm - RWE for Patient Experience & Tolerability

Capturing real‑world symptom burden to complement clinical trial data
Linking RWE insights to clinical decision‑making and patient support strategies
Improving post‑market understanding of tolerability and long‑term outcomes
Enhancing safety signal detection through continuous real‑world monitoring

4:45 pm- AI Governance in Clinical Development

Building risk‑proportionate oversight frameworks for AI‑enabled clinical tools
Establishing transparency and explainability standards for algorithmic decision‑making
Managing bias and ensuring fairness in clinical algorithms and predictive models
Creating cross‑functional governance structures that support responsible innovation

5:10 pm - Target Product Profile Co‑Creation with Patients

Aligning product goals with lived experience to ensure relevance and value
Prioritising outcomes that matter most to patients and caregivers
Improving development decision‑making through structured co‑design processes
Case examples demonstrating how patient input reshapes TPP priorities

5:35 pm - The Future of Patient Engagement: What Will Define Leadership in 2027–2030?

Ethical digital transformation that prioritises patient autonomy and safety
Global equity strategies that ensure inclusive access to research and care
Patient‑driven innovation models that reshape development priorities
New expectations for transparency, accountability, and partners

Moderator:

Panellists:

6:15 pm - CHAIRPERSON’S CLOSING REMARKS

6:20 pm - 7:20 pm - NETWORKING DRINK RECEPTION

8:00 am - WELCOME COFFEE & REGISTRATION

8:30 am - CHAIRPERSON’S OPENING REMARKS

Stephen O’Farrell, Executive Director, Spectrum Science

Frida Forya, Senior Quality Solutions Lead. Roche

DIGITAL TRIALS, AI GOVERNANCE & COLLABORATIVE RESEARCH

8:40 am - OPENING KEYNOTE PANEL: The Digital Transformation of Clinical Research: What’s Next?

AI‑enabled protocol optimisation that reduces burden and improves feasibility
Digital‑first patient experience models that streamline participation
Strengthening data integrity and governance in increasingly digital ecosystems
Aligning global regulatory expectations for digital and decentralised research

Moderator:

Panellists:
Lara Bloom, President and CEO, The Ehlers-Danlos Society

9:20 am - KEYNOTE PRESENTATION: Beyond the Checkbox: Redefining Diversity in Modern Clinical Trials

Moving past race and ethnicity to actively include underserved groups
Designing decentralized trials that solve real-world obstacles
Understanding the UK’s shift toward structured Inclusion and Diversity Plans over strict legal mandates
Proving how true participant representation directly leads to safer, more effective medicines for the entire population.

9:45 am - KEYNOTE PRESENTATION: Patient Advocacy as a Strategic Force

Advocacy shaping policy, reimbursement, and clinical research agendas
Co‑creating trial designs with patient groups to improve relevance and feasibility
Strengthening community trust through transparent, collaborative engagement
Measuring advocacy impact through clear, meaningful indicators

10:10 am - Digital Patient Experience: Human‑Centred Design for Clinical Development

Designing intuitive digital tools that reduce complexity and improve usability
Automating routine tasks to reduce patient burden and streamline workflows
Improving communication pathways between patients, sites, and sponsors
Measuring digital satisfaction to guide continuous improvement

10:35 am - MORNING NETWORKING BREAK

11:15 am - SPOTLIGHT PRESENTATION: AI‑Driven Feasibility & Site Intelligence

Predictive modelling that identifies optimal sites and patient populations
Diversity‑focused feasibility approaches that improve representation
Real‑time operational insights that support proactive decision‑making
Automated risk detection that enhances quality and compliance

11:45 am - SPOTLIGHT PRESENTATION: Digital Consent & Patient Onboarding Solutions

Simplifying complex information through interactive, accessible digital formats
Improving comprehension and retention using multimedia and adaptive content
Supporting multilingual and low‑literacy populations with tailored materials
Ensuring compliance through secure, audit‑ready documentation

12:15 am - SPOTLIGHT PRESENTATION: Remote Patient Support & Monitoring Platforms

Continuous digital engagement that strengthens patient confidence and safety
Symptom tracking and triage tools that support early intervention
Integrated care coordination that connects patients, sites, and providers
Data‑driven personalisation that improves outcomes and satisfaction

12:45 pm - Modern Patient Partnerships: From Engagement to Co‑Ownership

Building shared decision‑making models that elevate patient authority
Establishing patient governance boards that influence strategic direction
Co‑creating research priorities that reflect lived experience and unmet needs
Creating long‑term partnership value through sustained collaboration

1:15 pm - NETWORKING LUNCH

2:15 pm - PLENARY SESSION: RWE‑Driven Patient Experience Improvement

Linking real‑world data to patient outcomes to identify actionable insights
Using RWE to uncover unmet needs and inform support programme design
Improving post‑market safety understanding through continuous monitoring
Enhancing patient support through personalised, data‑driven interventions

2:40 pm - Designing Accessible Digital Health Tools

Creating inclusive UX that accommodates diverse abilities and backgrounds
Reducing digital burden through intuitive navigation and simplified workflows
Testing usability with patient partners to ensure real‑world relevance
Meeting accessibility standards to support equitable digital participation

3:05 pm - Patient‑Centric Communication Strategies

Crafting clear, empathetic messaging that supports informed decision‑making
Designing multi‑channel communication journeys that meet patients where they are
Addressing misinformation through proactive, evidence‑based content
Improving comprehension and trust through consistent, transparent communication

3:30 pm - AFTERNOON NETWORKING BREAK

4:00 pm - PANEL DISCUSSION: The Evolving Role of Patient Organisations

Advocacy shaping clinical, regulatory, and policy agendas across regions
Building global coalitions that amplify patient voice and influence
Strengthening research partnerships through structured collaboration models
Measuring advocacy impact through meaningful, transparent indicators

Moderator:

Panellists:
Gunnar Philip, Head of Medical Affairs Europe Major Markets and Canada, CSL

4:40 pm - CLOSING PANEL DISCUSSION: The Future of Patient‑Centric Innovation: What Will Matter Most?

Ethical AI and digital governance that protect patient autonomy and safety
Global equity strategies that ensure inclusive access to research and care
Patient‑driven research models that reshape development priorities
The next frontier of collaboration between patients, industry, and regulators

Moderator:

Panellists:

5:20 pm - CHAIRPERSON’S CLOSING REMARKS

Event Partners

Sponsors & Exhibitors - Patient Centricity & Collaboration World Congress 2026 Europe

Gold Sponsor

Silver Sponsor

Bronze Sponsor

Exhibitor

Associate Sponsor

Basic Sponsor

Become a sponsor/exhibitor

Co-located with:

Website: www.decentralizedtrialscongress.co.uk

Newsletter Sign Up

No Spam – You will only receive relevant information on Patient Centricity & Collaboration, and event updates

Testimonials

what people say

Thank you for a good experience with the PARADIGM Global Events… very high level, very good Organization, we overpassed our expectatives, we will be pending for another congress related to pharmaceutical and biotech… we learned a lot, and i think that the content of agenda was state of the art, thank you again.

Salvador Berrios

ERP/ CRM / Product Configurator Manager

The consistently high quality of international faculty was most impressive. It was also obvious that they were carefully chosen not only for their particular expertise but also for their ability to communicate the subject matter to clinical and non-clinical participants alike. As market access consultant for pharma clients of various sizes, I now feel much better prepared to explain the nuances & dynamics involved in bringing their products to market. In addition, I am in a much better position to intelligently advice my clients & help them set realistic expectations

Thomas Martin

Associate Vice President, VCGA - Quintiles

I was impressed with the organization of this event. I attend many conferences per year and find the organizers on site to be detached and not focus on good service to the delegates. This team was even providing weather forecast warning to ensure everyone was aware and made appropriate plans. Well Done.